which is heading for phase 2 trials in cardiomyopathy associated with ATTR amyloidosis, a life-threatening disease affecting the heart and nervous system. Novo Nordisk also gets rights to the ...

repair and reverse diseases of the heart.” The acquisition of Cardior is part of a wider strategy by Novo Nordisk to establish itself as a leader in the treatment of cardiovascular disease.

Novo Nordisk on Saturday said its diabetes pill ... become a new treatment option for people living with diabetes and heart disease. The pill lowered the risk of cardiovascular-related death ...

After revolutionizing the weight-loss drug market, Novo ... disease and chronic kidney disease, compared with a placebo. Novo Nordisk’s chief rival, Eli Lilly, also released new heart health ...

The Food and Drug Administration approved Novo ... events such as heart attacks and strokes. Novo Nordisk is also studying ...